The significance of CCAATenhancer binding protein beta (CEBPbeta) that directs IL-18BP activation in hepatoma cells [47] and murine cardiomyocytes [49] remains to be fully elucidated in the context of skin resident cells. This evidence concerns the gene CEBPB and hepatocellular carcinoma.